Kamada (KMDA) Change in Cash (2013 - 2026)
Kamada (KMDA) posted quarterly Change in Cash of -$42.5 million for Q1 2026, down 1847.23% year-on-year from $2.4 million in Q1 2025, and down 1325.43% on a QoQ basis from $3.5 million in Q4 2025.
Kamada (KMDA) Change in Cash (2013 - 2026) Analysis & Trends
Kamada (KMDA) has reported Change in Cash for 14 consecutive years, with -$42.5 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Cash fell 1847.23% year-over-year to -$42.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.3 million (down 254.43% YoY) and the FY2025 annual result came in at -$3.0 million, down 113.01% from the prior year.
- Change in Cash fell to -$42.5 million in Q1 2026 per KMDA's latest filing, from $3.5 million in the prior quarter.
- Over the last five years, Change in Cash for KMDA reached as high as $30.8 million in Q3 2023 and fell as low as -$42.5 million in Q1 2026.
- A 5-year average of $1.2 million and a median of $3.0 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash jumped 2336139.58% — and 2024, when it slumped 104243.56%.
- Year by year, Change in Cash stood at $3.0 million in 2022, then gained by 1.06% to $3.0 million in 2023, then soared by 111.78% to $6.4 million in 2024, then slumped by 46.04% to $3.5 million in 2025, then tumbled by 1325.43% to -$42.5 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$42.5 million, $3.5 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -42.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.55 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 6.01 Mn |
| Jun 30, 2025 | -10.27 Mn |
| Mar 31, 2025 | -2.19 Mn |
| Dec 31, 2024 | 6.43 Mn |
| Sep 30, 2024 | 15.45 Mn |
| Jun 30, 2024 | 8.35 Mn |
| Mar 31, 2024 | -7.45 Mn |
| Dec 31, 2023 | 3.04 Mn |
| Sep 30, 2023 | 30.82 Mn |
| Jun 30, 2023 | -5.33 Mn |
| Mar 31, 2023 | -7,137.00 |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 1,319.00 |
| Jun 30, 2022 | 7.97 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Dec 31, 2021 | -81.25 Mn |
| Sep 30, 2021 | 31.42 Mn |
| Jun 30, 2021 | 6.98 Mn |